These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
463 related items for PubMed ID: 16715122
21. Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands. Tedford CE, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Handley MK, Yates SL. J Pharmacol Exp Ther; 1999 May; 289(2):1160-8. PubMed ID: 10215700 [Abstract] [Full Text] [Related]
22. Differential effect of sodium ions and guanine nucleotides on the binding of thioperamide and clobenpropit to histamine H3-receptors in rat cerebral cortical membranes. Clark EA, Hill SJ. Br J Pharmacol; 1995 Jan; 114(2):357-62. PubMed ID: 7881735 [Abstract] [Full Text] [Related]
28. Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, [125I]-iodophenpropit, to rat brain. Jansen FP, Wu TS, Voss HP, Steinbusch HW, Vollinga RC, Rademaker B, Bast A, Timmerman H. Br J Pharmacol; 1994 Oct; 113(2):355-62. PubMed ID: 7834183 [Abstract] [Full Text] [Related]
29. Steroid-sensitivity of agonist binding to pituitary cell line histamine H3 receptors. West RE, Myers J, Zweig A, Siegel MI, Egan RW, Clark MA. Eur J Pharmacol; 1994 May 17; 267(3):343-8. PubMed ID: 8088374 [Abstract] [Full Text] [Related]
30. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons. Dai H, Fu Q, Shen Y, Hu W, Zhang Z, Timmerman H, Leurs R, Chen Z. Eur J Pharmacol; 2007 Jun 01; 563(1-3):117-23. PubMed ID: 17350613 [Abstract] [Full Text] [Related]
31. Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit. Jansen FP, Mochizuki T, Maeyama K, Leurs R, Timmerman H. Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul 01; 362(1):60-7. PubMed ID: 10935534 [Abstract] [Full Text] [Related]
32. Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin. Clark EA, Hill SJ. Eur J Pharmacol; 1996 Jan 25; 296(2):223-5. PubMed ID: 8838460 [Abstract] [Full Text] [Related]
33. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands. Yates SL, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Tedford CE. J Pharmacol Exp Ther; 1999 May 25; 289(2):1151-9. PubMed ID: 10215699 [Abstract] [Full Text] [Related]
34. Selective histamine H₃ and H₄ receptor agonists exert opposite effects against the gastric lesions induced by HCl in the rat stomach. Coruzzi G, Adami M, Pozzoli C, de Esch IJ, Smits R, Leurs R. Eur J Pharmacol; 2011 Nov 01; 669(1-3):121-7. PubMed ID: 21839070 [Abstract] [Full Text] [Related]
35. Binding characteristics of a histamine H3-receptor antagonist, [3H]S-methylthioperamide: comparison with [3H](R)alpha-methylhistamine binding to rat tissues. Yanai K, Ryu JH, Sakai N, Takahashi T, Iwata R, Ido T, Murakami K, Watanabe T. Jpn J Pharmacol; 1994 Jun 01; 65(2):107-12. PubMed ID: 7967223 [Abstract] [Full Text] [Related]
36. Generation of cell lines for drug discovery through random activation of gene expression: application to the human histamine H3 receptor. Song J, Doucette C, Hanniford D, Hunady K, Wang N, Sherf B, Harrington JJ, Brunden KR, Stricker-Krongrad A. Assay Drug Dev Technol; 2005 Jun 01; 3(3):309-18. PubMed ID: 15971992 [Abstract] [Full Text] [Related]
37. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J. J Pharmacol Exp Ther; 1998 Nov 01; 287(2):658-66. PubMed ID: 9808693 [Abstract] [Full Text] [Related]
38. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. Garbarg M, Arrang JM, Rouleau A, Ligneau X, Tuong MD, Schwartz JC, Ganellin CR. J Pharmacol Exp Ther; 1992 Oct 01; 263(1):304-10. PubMed ID: 1383495 [Abstract] [Full Text] [Related]
39. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type. Plazzi PV, Mor M, Bordi F, Silva C, Rivara S, Caretta A, Ballabeni V, Impicciatore M, Vitali T. Farmaco; 1997 May 01; 52(5):295-302. PubMed ID: 9274000 [Abstract] [Full Text] [Related]
40. Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain. Ishikawa M, Watanabe T, Kudo T, Yokoyama F, Yamauchi M, Kato K, Kakui N, Sato Y. J Med Chem; 2010 Sep 09; 53(17):6445-56. PubMed ID: 20690643 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]